ID: ALA4463544
Chembl Id: CHEMBL4463544
PubChem CID: 155529844
Max Phase: Preclinical
Molecular Formula: C14H17ClN6
Molecular Weight: 304.79
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1ncc(N2CCN(c3ccccc3Cl)CC2)c(N)n1
Standard InChI: InChI=1S/C14H17ClN6/c15-10-3-1-2-4-11(10)20-5-7-21(8-6-20)12-9-18-14(17)19-13(12)16/h1-4,9H,5-8H2,(H4,16,17,18,19)
Standard InChI Key: NNIGIVZLOKIULW-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 304.79 | Molecular Weight (Monoisotopic): 304.1203 | AlogP: 1.62 | #Rotatable Bonds: 2 |
| Polar Surface Area: 84.30 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 7.50 | CX LogP: 2.12 | CX LogD: 1.78 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.88 | Np Likeness Score: -1.12 |
| 1. Hopper AT, Brockman A, Wise A, Gould J, Barks J, Radke JB, Sibley LD, Zou Y, Thomas S.. (2019) Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis., 62 (3): [PMID:30624926] [10.1021/acs.jmedchem.8b01754] |
Source(1):
